COVID-19 Impact on Global Transdermal Drug Delivery Systems Market Size, Status and Forecast 2020-2026

August 2020 | 126 pages | ID: C7DF410BA4C4EN
QYResearch

Abstracts

This report focuses on the global Transdermal Drug Delivery Systems status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Transdermal Drug Delivery Systems development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Hisamitsu
• Mylan
• GSK
• Novartis
• Teve(Actavis)
• Johnson & Johnson
• UCB
• Teikoku Seiyaku
• Bayer
• Lingrui
• Sanofi
• Qizheng
• Endo
• Huarun 999
• Haw Par
• Nichiban
• Mentholatum Company
• Laboratoires Genevrier

Market segment by Type, the product can be split into

• Fentanyl
• Nitroglycerin
• Estradiol
• Nicotine
• Other

Market segment by Application, split into

• OTC
• Rx

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Transdermal Drug Delivery Systems status, future forecast, growth opportunity, key market and key players.
• To present the Transdermal Drug Delivery Systems development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Transdermal Drug Delivery Systems are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Transdermal Drug Delivery Systems Revenue
1.4 Market Analysis by Type
  1.4.1 Global Transdermal Drug Delivery Systems Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Fentanyl
  1.4.3 Nitroglycerin
  1.4.4 Estradiol
  1.4.5 Nicotine
  1.4.6 Other
1.5 Market by Application
  1.5.1 Global Transdermal Drug Delivery Systems Market Share by Application: 2020 VS 2026
  1.5.2 OTC
  1.5.3 Rx
1.6 Coronavirus Disease 2019 (Covid-19): Transdermal Drug Delivery Systems Industry Impact
  1.6.1 How the Covid-19 is Affecting the Transdermal Drug Delivery Systems Industry
    1.6.1.1 Transdermal Drug Delivery Systems Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Transdermal Drug Delivery Systems Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Transdermal Drug Delivery Systems Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Transdermal Drug Delivery Systems Market Perspective (2015-2026)
2.2 Transdermal Drug Delivery Systems Growth Trends by Regions
  2.2.1 Transdermal Drug Delivery Systems Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Transdermal Drug Delivery Systems Historic Market Share by Regions (2015-2020)
  2.2.3 Transdermal Drug Delivery Systems Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Transdermal Drug Delivery Systems Market Growth Strategy
  2.3.6 Primary Interviews with Key Transdermal Drug Delivery Systems Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Transdermal Drug Delivery Systems Players by Market Size
  3.1.1 Global Top Transdermal Drug Delivery Systems Players by Revenue (2015-2020)
  3.1.2 Global Transdermal Drug Delivery Systems Revenue Market Share by Players (2015-2020)
  3.1.3 Global Transdermal Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Transdermal Drug Delivery Systems Market Concentration Ratio
  3.2.1 Global Transdermal Drug Delivery Systems Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Transdermal Drug Delivery Systems Revenue in 2019
3.3 Transdermal Drug Delivery Systems Key Players Head office and Area Served
3.4 Key Players Transdermal Drug Delivery Systems Product Solution and Service
3.5 Date of Enter into Transdermal Drug Delivery Systems Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Transdermal Drug Delivery Systems Historic Market Size by Type (2015-2020)
4.2 Global Transdermal Drug Delivery Systems Forecasted Market Size by Type (2021-2026)

5 TRANSDERMAL DRUG DELIVERY SYSTEMS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Transdermal Drug Delivery Systems Market Size by Application (2015-2020)
5.2 Global Transdermal Drug Delivery Systems Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Transdermal Drug Delivery Systems Market Size (2015-2020)
6.2 Transdermal Drug Delivery Systems Key Players in North America (2019-2020)
6.3 North America Transdermal Drug Delivery Systems Market Size by Type (2015-2020)
6.4 North America Transdermal Drug Delivery Systems Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Transdermal Drug Delivery Systems Market Size (2015-2020)
7.2 Transdermal Drug Delivery Systems Key Players in Europe (2019-2020)
7.3 Europe Transdermal Drug Delivery Systems Market Size by Type (2015-2020)
7.4 Europe Transdermal Drug Delivery Systems Market Size by Application (2015-2020)

8 CHINA

8.1 China Transdermal Drug Delivery Systems Market Size (2015-2020)
8.2 Transdermal Drug Delivery Systems Key Players in China (2019-2020)
8.3 China Transdermal Drug Delivery Systems Market Size by Type (2015-2020)
8.4 China Transdermal Drug Delivery Systems Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Transdermal Drug Delivery Systems Market Size (2015-2020)
9.2 Transdermal Drug Delivery Systems Key Players in Japan (2019-2020)
9.3 Japan Transdermal Drug Delivery Systems Market Size by Type (2015-2020)
9.4 Japan Transdermal Drug Delivery Systems Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Transdermal Drug Delivery Systems Market Size (2015-2020)
10.2 Transdermal Drug Delivery Systems Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Transdermal Drug Delivery Systems Market Size by Type (2015-2020)
10.4 Southeast Asia Transdermal Drug Delivery Systems Market Size by Application (2015-2020)

11 INDIA

11.1 India Transdermal Drug Delivery Systems Market Size (2015-2020)
11.2 Transdermal Drug Delivery Systems Key Players in India (2019-2020)
11.3 India Transdermal Drug Delivery Systems Market Size by Type (2015-2020)
11.4 India Transdermal Drug Delivery Systems Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Transdermal Drug Delivery Systems Market Size (2015-2020)
12.2 Transdermal Drug Delivery Systems Key Players in Central & South America (2019-2020)
12.3 Central & South America Transdermal Drug Delivery Systems Market Size by Type (2015-2020)
12.4 Central & South America Transdermal Drug Delivery Systems Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Hisamitsu
  13.1.1 Hisamitsu Company Details
  13.1.2 Hisamitsu Business Overview and Its Total Revenue
  13.1.3 Hisamitsu Transdermal Drug Delivery Systems Introduction
  13.1.4 Hisamitsu Revenue in Transdermal Drug Delivery Systems Business (2015-2020))
  13.1.5 Hisamitsu Recent Development
13.2 Mylan
  13.2.1 Mylan Company Details
  13.2.2 Mylan Business Overview and Its Total Revenue
  13.2.3 Mylan Transdermal Drug Delivery Systems Introduction
  13.2.4 Mylan Revenue in Transdermal Drug Delivery Systems Business (2015-2020)
  13.2.5 Mylan Recent Development
13.3 GSK
  13.3.1 GSK Company Details
  13.3.2 GSK Business Overview and Its Total Revenue
  13.3.3 GSK Transdermal Drug Delivery Systems Introduction
  13.3.4 GSK Revenue in Transdermal Drug Delivery Systems Business (2015-2020)
  13.3.5 GSK Recent Development
13.4 Novartis
  13.4.1 Novartis Company Details
  13.4.2 Novartis Business Overview and Its Total Revenue
  13.4.3 Novartis Transdermal Drug Delivery Systems Introduction
  13.4.4 Novartis Revenue in Transdermal Drug Delivery Systems Business (2015-2020)
  13.4.5 Novartis Recent Development
13.5 Teve(Actavis)
  13.5.1 Teve(Actavis) Company Details
  13.5.2 Teve(Actavis) Business Overview and Its Total Revenue
  13.5.3 Teve(Actavis) Transdermal Drug Delivery Systems Introduction
  13.5.4 Teve(Actavis) Revenue in Transdermal Drug Delivery Systems Business (2015-2020)
  13.5.5 Teve(Actavis) Recent Development
13.6 Johnson & Johnson
  13.6.1 Johnson & Johnson Company Details
  13.6.2 Johnson & Johnson Business Overview and Its Total Revenue
  13.6.3 Johnson & Johnson Transdermal Drug Delivery Systems Introduction
  13.6.4 Johnson & Johnson Revenue in Transdermal Drug Delivery Systems Business (2015-2020)
  13.6.5 Johnson & Johnson Recent Development
13.7 UCB
  13.7.1 UCB Company Details
  13.7.2 UCB Business Overview and Its Total Revenue
  13.7.3 UCB Transdermal Drug Delivery Systems Introduction
  13.7.4 UCB Revenue in Transdermal Drug Delivery Systems Business (2015-2020)
  13.7.5 UCB Recent Development
13.8 Teikoku Seiyaku
  13.8.1 Teikoku Seiyaku Company Details
  13.8.2 Teikoku Seiyaku Business Overview and Its Total Revenue
  13.8.3 Teikoku Seiyaku Transdermal Drug Delivery Systems Introduction
  13.8.4 Teikoku Seiyaku Revenue in Transdermal Drug Delivery Systems Business (2015-2020)
  13.8.5 Teikoku Seiyaku Recent Development
13.9 Bayer
  13.9.1 Bayer Company Details
  13.9.2 Bayer Business Overview and Its Total Revenue
  13.9.3 Bayer Transdermal Drug Delivery Systems Introduction
  13.9.4 Bayer Revenue in Transdermal Drug Delivery Systems Business (2015-2020)
  13.9.5 Bayer Recent Development
13.10 Lingrui
  13.10.1 Lingrui Company Details
  13.10.2 Lingrui Business Overview and Its Total Revenue
  13.10.3 Lingrui Transdermal Drug Delivery Systems Introduction
  13.10.4 Lingrui Revenue in Transdermal Drug Delivery Systems Business (2015-2020)
  13.10.5 Lingrui Recent Development
13.11 Sanofi
  10.11.1 Sanofi Company Details
  10.11.2 Sanofi Business Overview and Its Total Revenue
  10.11.3 Sanofi Transdermal Drug Delivery Systems Introduction
  10.11.4 Sanofi Revenue in Transdermal Drug Delivery Systems Business (2015-2020)
  10.11.5 Sanofi Recent Development
13.12 Qizheng
  10.12.1 Qizheng Company Details
  10.12.2 Qizheng Business Overview and Its Total Revenue
  10.12.3 Qizheng Transdermal Drug Delivery Systems Introduction
  10.12.4 Qizheng Revenue in Transdermal Drug Delivery Systems Business (2015-2020)
  10.12.5 Qizheng Recent Development
13.13 Endo
  10.13.1 Endo Company Details
  10.13.2 Endo Business Overview and Its Total Revenue
  10.13.3 Endo Transdermal Drug Delivery Systems Introduction
  10.13.4 Endo Revenue in Transdermal Drug Delivery Systems Business (2015-2020)
  10.13.5 Endo Recent Development
13.14 Huarun
  10.14.1 Huarun 999 Company Details
  10.14.2 Huarun 999 Business Overview and Its Total Revenue
  10.14.3 Huarun 999 Transdermal Drug Delivery Systems Introduction
  10.14.4 Huarun 999 Revenue in Transdermal Drug Delivery Systems Business (2015-2020)
  10.14.5 Huarun 999 Recent Development
13.15 Haw Par
  10.15.1 Haw Par Company Details
  10.15.2 Haw Par Business Overview and Its Total Revenue
  10.15.3 Haw Par Transdermal Drug Delivery Systems Introduction
  10.15.4 Haw Par Revenue in Transdermal Drug Delivery Systems Business (2015-2020)
  10.15.5 Haw Par Recent Development
13.16 Nichiban
  10.16.1 Nichiban Company Details
  10.16.2 Nichiban Business Overview and Its Total Revenue
  10.16.3 Nichiban Transdermal Drug Delivery Systems Introduction
  10.16.4 Nichiban Revenue in Transdermal Drug Delivery Systems Business (2015-2020)
  10.16.5 Nichiban Recent Development
13.17 Mentholatum Company
  10.17.1 Mentholatum Company Company Details
  10.17.2 Mentholatum Company Business Overview and Its Total Revenue
  10.17.3 Mentholatum Company Transdermal Drug Delivery Systems Introduction
  10.17.4 Mentholatum Company Revenue in Transdermal Drug Delivery Systems Business (2015-2020)
  10.17.5 Mentholatum Company Recent Development
13.18 Laboratoires Genevrier
  10.18.1 Laboratoires Genevrier Company Details
  10.18.2 Laboratoires Genevrier Business Overview and Its Total Revenue
  10.18.3 Laboratoires Genevrier Transdermal Drug Delivery Systems Introduction
  10.18.4 Laboratoires Genevrier Revenue in Transdermal Drug Delivery Systems Business (2015-2020)
  10.18.5 Laboratoires Genevrier Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Transdermal Drug Delivery Systems Key Market Segments
Table 2. Key Players Covered: Ranking by Transdermal Drug Delivery Systems Revenue
Table 3. Ranking of Global Top Transdermal Drug Delivery Systems Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Transdermal Drug Delivery Systems Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Fentanyl
Table 6. Key Players of Nitroglycerin
Table 7. Key Players of Estradiol
Table 8. Key Players of Nicotine
Table 9. Key Players of Other
Table 10. COVID-19 Impact Global Market: (Four Transdermal Drug Delivery Systems Market Size Forecast Scenarios)
Table 11. Opportunities and Trends for Transdermal Drug Delivery Systems Players in the COVID-19 Landscape
Table 12. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 13. Key Regions/Countries Measures against Covid-19 Impact
Table 14. Proposal for Transdermal Drug Delivery Systems Players to Combat Covid-19 Impact
Table 15. Global Transdermal Drug Delivery Systems Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 16. Global Transdermal Drug Delivery Systems Market Size by Regions (US$ Million): 2020 VS 2026
Table 17. Global Transdermal Drug Delivery Systems Market Size by Regions (2015-2020) (US$ Million)
Table 18. Global Transdermal Drug Delivery Systems Market Share by Regions (2015-2020)
Table 19. Global Transdermal Drug Delivery Systems Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 20. Global Transdermal Drug Delivery Systems Market Share by Regions (2021-2026)
Table 21. Market Top Trends
Table 22. Key Drivers: Impact Analysis
Table 23. Key Challenges
Table 24. Transdermal Drug Delivery Systems Market Growth Strategy
Table 25. Main Points Interviewed from Key Transdermal Drug Delivery Systems Players
Table 26. Global Transdermal Drug Delivery Systems Revenue by Players (2015-2020) (Million US$)
Table 27. Global Transdermal Drug Delivery Systems Market Share by Players (2015-2020)
Table 28. Global Top Transdermal Drug Delivery Systems Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Transdermal Drug Delivery Systems as of 2019)
Table 29. Global Transdermal Drug Delivery Systems by Players Market Concentration Ratio (CR5 and HHI)
Table 30. Key Players Headquarters and Area Served
Table 31. Key Players Transdermal Drug Delivery Systems Product Solution and Service
Table 32. Date of Enter into Transdermal Drug Delivery Systems Market
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Transdermal Drug Delivery Systems Market Size by Type (2015-2020) (Million US$)
Table 35. Global Transdermal Drug Delivery Systems Market Size Share by Type (2015-2020)
Table 36. Global Transdermal Drug Delivery Systems Revenue Market Share by Type (2021-2026)
Table 37. Global Transdermal Drug Delivery Systems Market Size Share by Application (2015-2020)
Table 38. Global Transdermal Drug Delivery Systems Market Size by Application (2015-2020) (Million US$)
Table 39. Global Transdermal Drug Delivery Systems Market Size Share by Application (2021-2026)
Table 40. North America Key Players Transdermal Drug Delivery Systems Revenue (2019-2020) (Million US$)
Table 41. North America Key Players Transdermal Drug Delivery Systems Market Share (2019-2020)
Table 42. North America Transdermal Drug Delivery Systems Market Size by Type (2015-2020) (Million US$)
Table 43. North America Transdermal Drug Delivery Systems Market Share by Type (2015-2020)
Table 44. North America Transdermal Drug Delivery Systems Market Size by Application (2015-2020) (Million US$)
Table 45. North America Transdermal Drug Delivery Systems Market Share by Application (2015-2020)
Table 46. Europe Key Players Transdermal Drug Delivery Systems Revenue (2019-2020) (Million US$)
Table 47. Europe Key Players Transdermal Drug Delivery Systems Market Share (2019-2020)
Table 48. Europe Transdermal Drug Delivery Systems Market Size by Type (2015-2020) (Million US$)
Table 49. Europe Transdermal Drug Delivery Systems Market Share by Type (2015-2020)
Table 50. Europe Transdermal Drug Delivery Systems Market Size by Application (2015-2020) (Million US$)
Table 51. Europe Transdermal Drug Delivery Systems Market Share by Application (2015-2020)
Table 52. China Key Players Transdermal Drug Delivery Systems Revenue (2019-2020) (Million US$)
Table 53. China Key Players Transdermal Drug Delivery Systems Market Share (2019-2020)
Table 54. China Transdermal Drug Delivery Systems Market Size by Type (2015-2020) (Million US$)
Table 55. China Transdermal Drug Delivery Systems Market Share by Type (2015-2020)
Table 56. China Transdermal Drug Delivery Systems Market Size by Application (2015-2020) (Million US$)
Table 57. China Transdermal Drug Delivery Systems Market Share by Application (2015-2020)
Table 58. Japan Key Players Transdermal Drug Delivery Systems Revenue (2019-2020) (Million US$)
Table 59. Japan Key Players Transdermal Drug Delivery Systems Market Share (2019-2020)
Table 60. Japan Transdermal Drug Delivery Systems Market Size by Type (2015-2020) (Million US$)
Table 61. Japan Transdermal Drug Delivery Systems Market Share by Type (2015-2020)
Table 62. Japan Transdermal Drug Delivery Systems Market Size by Application (2015-2020) (Million US$)
Table 63. Japan Transdermal Drug Delivery Systems Market Share by Application (2015-2020)
Table 64. Southeast Asia Key Players Transdermal Drug Delivery Systems Revenue (2019-2020) (Million US$)
Table 65. Southeast Asia Key Players Transdermal Drug Delivery Systems Market Share (2019-2020)
Table 66. Southeast Asia Transdermal Drug Delivery Systems Market Size by Type (2015-2020) (Million US$)
Table 67. Southeast Asia Transdermal Drug Delivery Systems Market Share by Type (2015-2020)
Table 68. Southeast Asia Transdermal Drug Delivery Systems Market Size by Application (2015-2020) (Million US$)
Table 69. Southeast Asia Transdermal Drug Delivery Systems Market Share by Application (2015-2020)
Table 70. India Key Players Transdermal Drug Delivery Systems Revenue (2019-2020) (Million US$)
Table 71. India Key Players Transdermal Drug Delivery Systems Market Share (2019-2020)
Table 72. India Transdermal Drug Delivery Systems Market Size by Type (2015-2020) (Million US$)
Table 73. India Transdermal Drug Delivery Systems Market Share by Type (2015-2020)
Table 74. India Transdermal Drug Delivery Systems Market Size by Application (2015-2020) (Million US$)
Table 75. India Transdermal Drug Delivery Systems Market Share by Application (2015-2020)
Table 76. Central & South America Key Players Transdermal Drug Delivery Systems Revenue (2019-2020) (Million US$)
Table 77. Central & South America Key Players Transdermal Drug Delivery Systems Market Share (2019-2020)
Table 78. Central & South America Transdermal Drug Delivery Systems Market Size by Type (2015-2020) (Million US$)
Table 79. Central & South America Transdermal Drug Delivery Systems Market Share by Type (2015-2020)
Table 80. Central & South America Transdermal Drug Delivery Systems Market Size by Application (2015-2020) (Million US$)
Table 81. Central & South America Transdermal Drug Delivery Systems Market Share by Application (2015-2020)
Table 82. Hisamitsu Company Details
Table 83. Hisamitsu Business Overview
Table 84. Hisamitsu Product
Table 85. Hisamitsu Revenue in Transdermal Drug Delivery Systems Business (2015-2020) (Million US$)
Table 86. Hisamitsu Recent Development
Table 87. Mylan Company Details
Table 88. Mylan Business Overview
Table 89. Mylan Product
Table 90. Mylan Revenue in Transdermal Drug Delivery Systems Business (2015-2020) (Million US$)
Table 91. Mylan Recent Development
Table 92. GSK Company Details
Table 93. GSK Business Overview
Table 94. GSK Product
Table 95. GSK Revenue in Transdermal Drug Delivery Systems Business (2015-2020) (Million US$)
Table 96. GSK Recent Development
Table 97. Novartis Company Details
Table 98. Novartis Business Overview
Table 99. Novartis Product
Table 100. Novartis Revenue in Transdermal Drug Delivery Systems Business (2015-2020) (Million US$)
Table 101. Novartis Recent Development
Table 102. Teve(Actavis) Company Details
Table 103. Teve(Actavis) Business Overview
Table 104. Teve(Actavis) Product
Table 105. Teve(Actavis) Revenue in Transdermal Drug Delivery Systems Business (2015-2020) (Million US$)
Table 106. Teve(Actavis) Recent Development
Table 107. Johnson & Johnson Company Details
Table 108. Johnson & Johnson Business Overview
Table 109. Johnson & Johnson Product
Table 110. Johnson & Johnson Revenue in Transdermal Drug Delivery Systems Business (2015-2020) (Million US$)
Table 111. Johnson & Johnson Recent Development
Table 112. UCB Company Details
Table 113. UCB Business Overview
Table 114. UCB Product
Table 115. UCB Revenue in Transdermal Drug Delivery Systems Business (2015-2020) (Million US$)
Table 116. UCB Recent Development
Table 117. Teikoku Seiyaku Business Overview
Table 118. Teikoku Seiyaku Product
Table 119. Teikoku Seiyaku Company Details
Table 120. Teikoku Seiyaku Revenue in Transdermal Drug Delivery Systems Business (2015-2020) (Million US$)
Table 121. Teikoku Seiyaku Recent Development
Table 122. Bayer Company Details
Table 123. Bayer Business Overview
Table 124. Bayer Product
Table 125. Bayer Revenue in Transdermal Drug Delivery Systems Business (2015-2020) (Million US$)
Table 126. Bayer Recent Development
Table 127. Lingrui Company Details
Table 128. Lingrui Business Overview
Table 129. Lingrui Product
Table 130. Lingrui Revenue in Transdermal Drug Delivery Systems Business (2015-2020) (Million US$)
Table 131. Lingrui Recent Development
Table 132. Sanofi Company Details
Table 133. Sanofi Business Overview
Table 134. Sanofi Product
Table 135. Sanofi Revenue in Transdermal Drug Delivery Systems Business (2015-2020) (Million US$)
Table 136. Sanofi Recent Development
Table 137. Qizheng Company Details
Table 138. Qizheng Business Overview
Table 139. Qizheng Product
Table 140. Qizheng Revenue in Transdermal Drug Delivery Systems Business (2015-2020) (Million US$)
Table 141. Qizheng Recent Development
Table 142. Endo Company Details
Table 143. Endo Business Overview
Table 144. Endo Product
Table 145. Endo Revenue in Transdermal Drug Delivery Systems Business (2015-2020) (Million US$)
Table 146. Endo Recent Development
Table 147. Huarun 999 Company Details
Table 148. Huarun 999 Business Overview
Table 149. Huarun 999 Product
Table 150. Huarun 999 Revenue in Transdermal Drug Delivery Systems Business (2015-2020) (Million US$)
Table 151. Huarun 999 Recent Development
Table 152. Haw Par Company Details
Table 153. Haw Par Business Overview
Table 154. Haw Par Product
Table 155. Haw Par Revenue in Transdermal Drug Delivery Systems Business (2015-2020) (Million US$)
Table 156. Haw Par Recent Development
Table 157. Nichiban Company Details
Table 158. Nichiban Business Overview
Table 159. Nichiban Product
Table 160. Nichiban Revenue in Transdermal Drug Delivery Systems Business (2015-2020) (Million US$)
Table 161. Nichiban Recent Development
Table 162. Mentholatum Company Company Details
Table 163. Mentholatum Company Business Overview
Table 164. Mentholatum Company Product
Table 165. Mentholatum Company Revenue in Transdermal Drug Delivery Systems Business (2015-2020) (Million US$)
Table 166. Mentholatum Company Recent Development
Table 167. Laboratoires Genevrier Company Details
Table 168. Laboratoires Genevrier Business Overview
Table 169. Laboratoires Genevrier Product
Table 170. Laboratoires Genevrier Revenue in Transdermal Drug Delivery Systems Business (2015-2020) (Million US$)
Table 171. Laboratoires Genevrier Recent Development
Table 172. Research Programs/Design for This Report
Table 173. Key Data Information from Secondary Sources
Table 174. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Transdermal Drug Delivery Systems Market Share by Type: 2020 VS 2026
Figure 2. Fentanyl Features
Figure 3. Nitroglycerin Features
Figure 4. Estradiol Features
Figure 5. Nicotine Features
Figure 6. Other Features
Figure 7. Global Transdermal Drug Delivery Systems Market Share by Application: 2020 VS 2026
Figure 8. OTC Case Studies
Figure 9. Rx Case Studies
Figure 10. Transdermal Drug Delivery Systems Report Years Considered
Figure 11. Global Transdermal Drug Delivery Systems Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Transdermal Drug Delivery Systems Market Share by Regions: 2020 VS 2026
Figure 13. Global Transdermal Drug Delivery Systems Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Transdermal Drug Delivery Systems Market Share by Players in 2019
Figure 16. Global Top Transdermal Drug Delivery Systems Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Transdermal Drug Delivery Systems as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Transdermal Drug Delivery Systems Revenue in 2019
Figure 18. North America Transdermal Drug Delivery Systems Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Transdermal Drug Delivery Systems Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Transdermal Drug Delivery Systems Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Transdermal Drug Delivery Systems Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Transdermal Drug Delivery Systems Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Transdermal Drug Delivery Systems Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Transdermal Drug Delivery Systems Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Hisamitsu Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Hisamitsu Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2015-2020)
Figure 27. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Mylan Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2015-2020)
Figure 29. GSK Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. GSK Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2015-2020)
Figure 31. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Novartis Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2015-2020)
Figure 33. Teve(Actavis) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Teve(Actavis) Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2015-2020)
Figure 35. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Johnson & Johnson Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2015-2020)
Figure 37. UCB Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. UCB Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2015-2020)
Figure 39. Teikoku Seiyaku Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Teikoku Seiyaku Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2015-2020)
Figure 41. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Bayer Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2015-2020)
Figure 43. Lingrui Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Lingrui Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2015-2020)
Figure 45. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. Sanofi Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2015-2020)
Figure 47. Qizheng Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. Qizheng Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2015-2020)
Figure 49. Endo Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Endo Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2015-2020)
Figure 51. Huarun 999 Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Huarun 999 Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2015-2020)
Figure 53. Haw Par Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Haw Par Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2015-2020)
Figure 55. Nichiban Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Nichiban Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2015-2020)
Figure 57. Mentholatum Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Mentholatum Company Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2015-2020)
Figure 59. Laboratoires Genevrier Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Laboratoires Genevrier Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2015-2020)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed